IN VIVO FLUORESCENCE SENSORS, SYSTEMS, AND RELATED METHODS OPERATING IN CONJUNCTION WITH FLUORESCENT ANALYTES
First Claim
1. A method for determining the in vivo clinical efficacy of a treatment in a subject, comprising:
- positioning at least one sensor in tissue in a region of interest in the body;
administering a fluorescent analyte to a subject, the fluorescent analyte including at least one of a fluorescently pre-labeled analyte, a naturally fluorescent analyte and an analyte that exhibits fluorescence when internally administered to the subject;
emitting at least one excitation light signal from the at least one sensor to tissue proximate the at least one sensor;
detecting in vivo from the at least one sensor a signal corresponding to the fluorescence in the region of interest in the subject responsive to the administering step;
relaying the signal to a location external of the subject'"'"'s body; and
monitoring the signal over time to determine the localized fluorescence response of the subject to the administered fluorescently pre-labeled analyte, naturally fluorescent analyte and/or analyte that exhibits fluorescence when in the subject.
3 Assignments
0 Petitions
Accused Products
Abstract
Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stimulate toxin release based on the confirmation; and (h) monitor for the expression of a protein produced from a gene therapy modification.
In particular embodiments, the intensity of the excitation signals emitted to the localized tissue can be varied in a predetermined manner to generate optical profiling data of the response of the tissue proximate the sensor.
15 Citations
30 Claims
-
1. A method for determining the in vivo clinical efficacy of a treatment in a subject, comprising:
-
positioning at least one sensor in tissue in a region of interest in the body; administering a fluorescent analyte to a subject, the fluorescent analyte including at least one of a fluorescently pre-labeled analyte, a naturally fluorescent analyte and an analyte that exhibits fluorescence when internally administered to the subject; emitting at least one excitation light signal from the at least one sensor to tissue proximate the at least one sensor; detecting in vivo from the at least one sensor a signal corresponding to the fluorescence in the region of interest in the subject responsive to the administering step; relaying the signal to a location external of the subject'"'"'s body; and monitoring the signal over time to determine the localized fluorescence response of the subject to the administered fluorescently pre-labeled analyte, naturally fluorescent analyte and/or analyte that exhibits fluorescence when in the subject. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
-
Specification